Join the Daclizumab group to help and get support from people like you.
Daclizumab News
FDA Approves Zinbryta (daclizumab) to Treat Multiple Sclerosis
May 27, 2016 – The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting...